Medtronic (NYSE:MDT) has appointed a former Dexcom leader as the new head of Americas for its Diabetes business unit.

The Dexcom 15-day G7 continuous glucose monitor (CGM) is accurate and safe ... on advisory boards and received consulting fees from Medtronic, Eli Lilly, Abbott Diabetes Care, and Novo Nordisk.

The letter also noted that the company does not monitor how acetaminophen affects glucose sensing with its G7 monitors. The FDA also said Dexcom is not properly evaluating the risk of using the G6 ...

The doctors say barriers continue to prevent access to AID, including costs. Such barriers exemplify “the implicit ...

Diabetes business represents around 7.7% of total revenue, growing at double-digit in the recent quarters, driven by strong demand for Medtronic’s Continuous Glucose Monitoring (CGM) solutions.

All participants wore a Guardian 3 or 4 (Medtronic) continuous glucose monitor. Women in both groups were followed until hospital discharge after delivery. Women using the MiniMed 780G had a ...

Dexcom has a well-established record of introducing the most precise sensors for use in its continuous glucose monitors ... off competition from Abbott and Medtronic. Dexcom has begun to make ...